Management of asthma in school-aged children and adolescents

Pediatric Annals

Volumn 43, Issue 8, 2014, Pages

  Durrani, Sandy ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FORMOTEROL; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; METHYLXANTHINE; OMALIZUMAB; SALMETEROL; TIOTROPIUM BROMIDE; ZILEUTON; ANTIASTHMATIC AGENT; GLUCOCORTICOID;

ADOLESCENT; ALLERGY TEST; AROUSAL; ARTICLE; ASTHMA; BRONCHOSPASM; CAREGIVER; CHILD; DISEASE EXACERBATION; ENVIRONMENTAL FACTOR; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GASTROESOPHAGEAL REFLUX; HUMAN; INFLUENZA VACCINATION; LUNG FUNCTION; MILD PERSISTENT ASTHMA; MODERATE PERSISTENT ASTHMA; NOSE POLYP; SCHOOL CHILD; SEVERE PERSISTENT ASTHMA; SINUSITIS; SLEEP DISORDERED BREATHING; SMOKING; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; ADVERSE EFFECTS; COMORBIDITY; ENVIRONMENTAL EXPOSURE; FEMALE; INHALATIONAL DRUG ADMINISTRATION; MALE; PATHOPHYSIOLOGY; PATIENT EDUCATION; PATIENT REFERRAL; PRACTICE GUIDELINE; RISK FACTOR; SCHOOL; SEVERITY OF ILLNESS INDEX; STUDENT; TREATMENT OUTCOME; UNITED STATES;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; COMORBIDITY; ENVIRONMENTAL EXPOSURE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION; RISK FACTORS; SCHOOLS; SEVERITY OF ILLNESS INDEX; STUDENTS; TREATMENT OUTCOME; UNITED STATES;

EID: 84906263086     PISSN: 00904481     EISSN: 19382359     Source Type: Journal    
DOI: 10.3928/00904481-20140723-08     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention. Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001-2009. MMWR Morb Mortal Wkly Rep. 2011;60(17):547-552.
2. Lai CK, Beasley R, Crane J, et al. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2009;64(6):476-483.
3. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma: Full Report 2007. National Heart, Lung, and Blood Institute National Asthma Education and Prevention Program. http://www.nhlbi.nih.gov/guidelines/ asthma/asthgdln.pdf. Published July 1997. Updated August 2007. Accessed May 15, 2014.
4. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. http://www.ginasthma.org/. Updated May 2014. Accessed May 15, 2014.
5. Durrani SR, Busse WW. Management of asthma in adolescents and adults. In: Adkinson NF Jr, Bochner BS, Burks AW, et al, eds. Middleton's Allergy Principles and Practice. 8th ed. Philadelphia, PA: Elsevier/Saunders; 2014:909-922.
6. Jackson DJ, Lemanske Jr RF, Guilbert TW. Management of Asthma in Infants and Children. 8th ed. Philadelphia, PA: Elsevier/Saunders; 2014.
7. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2003(1):CD001117.
8. Platts-Mills TA. How environment affects patients with allergic disease: indoor allergens and asthma. Ann Allergy. 1994;72(4):381-384.
9. Rosenstreich DL, Eggleston P, Kattan M, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med. 1997;336(19):1356-1363.
10. Ahluwalia SK, Peng RD, Breysse PN, et al. Mouse allergen is the major allergen of public health relevance in Baltimore City. J Allergy Clin Immunol. 2013;132(4):830-835.e831-e832.
11. Kerkhof M, Wijga AH, Brunekreef B, et al. Effects of pets on asthma development up to 8 years of age: the PIAMA study. Allergy. 2009;64(8):1202-1208.
12. Gilliland FD, Islam T, Berhane K, et al. Regular smoking and asthma incidence in adolescents. Am J Respir Crit Care Med. 2006;174(10):1094-1100.
13. Carlsten C, Brauer M, Dimich-Ward H, Dybun-cio A, Becker AB, Chan-Yeung M. Combined exposure to dog and indoor pollution: incident asthma in a high-risk birth cohort. Eur Respir J. 2011;37(2):324-330.
14. Weitzman M, Gortmaker S, Walker DK, Sobol A. Maternal smoking and childhood asthma. Pe -diatrics. 1990;85(4):505-511.
15. Ng D, Salvio F, Hicks G. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev. 2004(2):CD002314.
16. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2006;354(19):1985-1997.
17. Sorkness CA, Lemanske RF Jr, Mauger DT, et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol. 2007;119(1):64-72.
18. Peters S P, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med. 2010;363(18):1715-1726.
19. Rodrigo GJ, Neffen H, Castro-Rodriguez JA. Efficacy and safety of subcutaneous omali-zumab vs placebo as add-on therapy to cortico-steroids for children and adults with asthma: a systematic review. Chest. 2011;139(1):28-35.
20. Approval notification: ORALAIR. US Food and Drug Administration. http://www.fda.gov/ downloads/BiologicsBloodVaccines/Allergen-ics/UCM391580.pdf. Accessed May 15, 2014.
21. Bacharier LB, Guilbert TW. Diagnosis and management of early asthma in preschool-aged children. J Allergy Clin Immunol. 2012;130(2):287-296.
22. Lemanske RF Jr, Mauger DT, Sorkness CA, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med. 2010;362(11):975-985.